Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-20
2006-06-20
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S221000, C514S228500, C514S234500, C514S252160, C514S262100, C540S460000, C540S502000
Reexamination Certificate
active
07064119
ABSTRACT:
A novel fused bicyclic pyrimidine derivative or a salt thereof that acts as a tachykinin receptor antagonist and, in particular, as an NK1 receptor antagonist is represented by the following general formula (1):wherein the rings A and B are each a benzene ring having 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring); the ring C is a nitrogen-containing ring; R is a hydrogen atom, a C1to C6alkyl group, a C1to C6alkylcarbonyl group, or a C1to C6alkylsulfonyl group; m is 1 or 2; and n is 2 or 3.
REFERENCES:
patent: 5770590 (1998-06-01), Natsugari et al.
patent: 9-263587 (1997-10-01), None
patent: 2002-348289 (2002-12-01), None
Ikeda Makoto
Izawa Shigeru
Seto Shigeki
Tanioka Asao
Kifle Bruck
Kyorin Pharmaceutical Co. Ltd.
LandOfFree
Fused bicyclic pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused bicyclic pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic pyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3619224